West Nile

Virus Spread Correlates With Climate Change in U.S. According to Healthline Study

Retrieved on: 
Thursday, August 20, 2020
General Health, Infectious diseases, Other Health, Environment, Health, Articles, Flaviviruses, Health, Global health, Rivers, Zoonoses, Healthline, Epidemiology, West Nile, Effects of global warming on human health, Nile, Virus

Rising temperatures brought on by climate change have contributed to a prevalence of cases of West Nile virus in the United States, according to a study released today.

Key Points: 
  • Rising temperatures brought on by climate change have contributed to a prevalence of cases of West Nile virus in the United States, according to a study released today.
  • The study, West Nile virus in the U.S.: A case study on climate change and health , is published in Medical News Today, sister site of Healthline.com , the flagship digital health brand of Healthline Media.
  • Understanding how West Nile virus spreads and its relationship to climate change helps us educate our audience about disease prevention, including West Nile and similar viruses.
  • Healthline Media is the top ranked health publisher and number 39 on Comscores Top 100 Property rankings through January 2020.

Mississippi Activist Takes Action After First West Nile Case Announced

Retrieved on: 
Friday, July 10, 2020
Flaviviruses, West Nile, Mosquito, Infectious diseases, Virus, Medical specialties, Tropical diseases, Organisms

The state of Mississippi officially announced its first case of West Nile virus in 2020, and, as mosquito season intensifies, WEEP aims to protect people from the deadly predators in their own backyards.

Key Points: 
  • The state of Mississippi officially announced its first case of West Nile virus in 2020, and, as mosquito season intensifies, WEEP aims to protect people from the deadly predators in their own backyards.
  • After he lost his son, Phillip, to a West Nile virus-related illness, Hendry made mosquito virus education his lifelong mission.
  • Even in the midst of the COVID outbreak, Hendry hopes that members of the Mississippi community will take the West Nile virus seriously.
  • WEEP & Recover is a registered 501-c3 organization dedicated to providing information about West Nile Virus prevention and eradication.

West Nile Virus Therapeutics Market 2019-2023 | Availability of Over-the-Counter (OTC) Therapeutics to Boost Growth | Technavio

Retrieved on: 
Monday, June 1, 2020
Infectious diseases, Pharmaceutical, Health, Pharmaceutical companies, Companies, Life sciences, Pfizer, Teva Pharmaceutical Industries, Mylan, West Nile, Novartis, GlaxoSmithKline, Perrigo

Our West Nile virus therapeutics market report covers the following areas:

Key Points: 
  • Our West Nile virus therapeutics market report covers the following areas:
    This study identifies rising awareness as one of the prime reasons driving the West Nile virus therapeutics market growth during the next few years.
  • West Nile Virus Therapeutics Market 2019-2023: Vendor Analysis
    We provide a detailed analysis of around 25 vendors operating in the West Nile Virus Therapeutics Market, including some of the vendors such as Aurobindo Pharma Ltd., Bayer AG, GlaxoSmithKline Plc, Granules India Ltd., Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Perrigo Co. Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
  • Backed with competitive intelligence and benchmarking, our research reports on the West Nile Virus Therapeutics Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • West Nile Virus Therapeutics Market 2019-2023: Key Highlights

West Nile Virus Therapeutics Market 2019-2023 | Availability of Over-the Counter (OTC) Therapeutics to Boost Growth |  Technavio

Retrieved on: 
Friday, February 14, 2020
Health, Pharmaceutical, Pharmaceutical companies, Companies, Life sciences, Pfizer, Teva Pharmaceutical Industries, West Nile, Mylan, Novartis, GlaxoSmithKline, Perrigo

Our west Nile virus therapeutics market report covers the following areas:

Key Points: 
  • Our west Nile virus therapeutics market report covers the following areas:
    This study identifies rising awareness as one of the prime reasons driving the west Nile virus therapeutics market growth during the next few years.
  • West Nile Virus Therapeutics Market 2019-2023: Vendor Analysis
    We provide a detailed analysis of around 25 vendors operating in the west Nile virus therapeutics market, including some of the vendors such as Aurobindo Pharma Ltd., Bayer AG, GlaxoSmithKline Plc, Granules India Ltd., Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Perrigo Co. Plc, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.
  • Backed with competitive intelligence and benchmarking, our research reports on the west Nile virus therapeutics market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • West Nile Virus Therapeutics Market 2019-2023: Key Highlights
    Technavio is a leading global technology research and advisory company.

West Nile Virus Infections - World Pipeline Review, H2 2019 - ResearchAndMarkets.com

Retrieved on: 
Monday, December 9, 2019
Infectious diseases, Pharmaceutical, Health, Animal diseases, Medicine, Veterinary medicine, Encephalitis, Flaviviruses, Tropical diseases, West Nile, Virus, Infection, Book:Common viral infections

The "West Nile Virus Infections - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "West Nile Virus Infections - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects.
  • The pipeline guide reviews pipeline therapeutics for West Nile Virus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Formulate corrective measures for pipeline projects by understanding West Nile Virus Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.

Global West Nile Virus Therapeutics Market 2019-2023 | Evolving Opportunities With Aurobindo Pharma Ltd. and Bayer AG | Technavio

Retrieved on: 
Tuesday, October 8, 2019
Biotechnology, Pharmaceutical, Health, Infectious diseases, Medical specialties, Animal diseases, Tropical diseases, Flaviviruses, Zoonoses, RTT, West Nile

View the full release here: https://www.businesswire.com/news/home/20191008005557/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191008005557/en/
    Technavio has announced its latest market research report titled global West Nile Virus therapeutics market 2019-2023.
  • Also, rising awareness is anticipated to further boost the growth of the West Nile Virus therapeutics market.
  • West Nile Virus infection does not have a specific drug or vaccine that is approved or ideal for patients.
  • These benefits boost patient adherence and will drive the growth of the West Nile Virus therapeutics market during the forecast period.